In 2022, Ergomed Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Ergomed Group has also provided a category-level breakdown for 2 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2022 | 2021 | 2020 | 2019 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Location-Based | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ergomed Group’s data sources below and access millions more through our Disclosure Search.
In 2022, the total operational greenhouse gas (GHG) emissions of Ergomed Group amounted to 15.02 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2021, the total operational greenhouse gas (GHG) emissions of Ergomed Group decreased by 41.12%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2022, the total Scope 1 emissions of Ergomed Group were 0.73 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2021), Ergomed Group's Scope 1 emissions increased by 1,116.67%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2022, Ergomed Group reported Scope 2 greenhouse gas (GHG) emissions of 18.88 tCO₂e using the market-based method and 14.29 tCO₂e using the location-based method.a
Compared to the previous year (2021), Ergomed Group's Scope 2 emissions (Location-Based) fell by 43.85% in 2022, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a
In 2022, Ergomed Group reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2022, Ergomed Group reported 27.02 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2022 disclosure of Ergomed Group includes a breakdown across 2 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2021, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2022, Ergomed Group reported total Scope 3 emissions of 27.02 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2021), Ergomed Group's Scope 3 emissions decreased by 14.55%, highlighting the company's efforts to lower indirect emissions from its value chain.a
In 2022, Ergomed Group reported emissions for 2 out of the 15 Scope 3 categories defined by the GHG Protocol.a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2022, the largest contributors to Ergomed Group's Scope 3 emissions were:a
In 2022, Ergomed Group reported a total carbon footprint of 42.04 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 26.41% decrease compared to 2021, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Ergomed Group's total carbon footprint was Scope 3 emissions, accounting for 64.27% of the company's total carbon footprint, followed by Scope 2 emissions at 33.99%.a